This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Norgine Bv. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Rajenda Kristam: Innovator in CCR9 Modulation
Introduction
Rajenda Kristam is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that modulate the CCR9 receptor. His work has implications for treating various inflammatory and immune disorders.
Latest Patents
Rajenda Kristam holds a patent for "Compounds useful as CCR9 modulators." This invention relates to compounds that can modulate the function of the CCR9 receptor by acting as partial agonists, antagonists, or inverse agonists. These compounds may be beneficial in treating, preventing, or ameliorating diseases associated with CCR9 activation, including inflammatory bowel diseases (IBD). He has 1 patent to his name.
Career Highlights
Rajenda Kristam is currently associated with Norgine Bv, where he continues to innovate in the field of pharmaceutical development. His expertise in CCR9 modulation positions him as a key player in addressing complex health issues related to immune responses.
Collaborations
Some of his notable coworkers include Rajagopal Bakthavatchalam and Manas Kumar Basu. Their collaborative efforts contribute to advancing research and development in their respective fields.
Conclusion
Rajenda Kristam's work in CCR9 modulation exemplifies the impact of innovative research on healthcare. His contributions are paving the way for new treatments for inflammatory and immune disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile